KK-LC-1 TCR gene-engineered T cells showed evidence of specific recognition of KK-LC-1 positive TNBC tumor cell lines in vitro and mediated regression of KK-LC-1 positive tumors in vivo87. This evidence concerns the gene CT83 and neoplasm.